Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about James Lanthier

Recent news which mentions James Lanthier

Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials
Tickers MSSTF
Tags Psychedelics Markets Cannabis
From Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
Tickers CYBN MSSTF
Tags Penny Stocks News Market News
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags MSSTF Cannabis major depressive disorder
From Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
Tickers MSSTF
Tags Market News News Penny Stocks
From Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
Tickers MSSTF
Tags MSSTF Drug Discovery Cannabis
From Benzinga
Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development
Tickers MSSTF
Tags Drug Discovery MSSTF Markets
From Benzinga
Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014
Tickers MSSTF
Tags James Lanthier Benzinga MSSTF
From Benzinga
Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders
Tickers MSSTF
Tags News the United States Patent and Trademark Office Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.